ljwei@jlu.edu.cnLijuan Wei

Prof. ljwei@jlu.edu.cnLijuan Wei


Research Focus & Metrics

Academic Career Length

9Years (2018-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 June 2018 in Chemico-Biological Interactions
Verified
Journal Article
Closed access
ljwei@jlu.edu.cnLijuan Weiljwei@jlu.edu.cnLijuan Wei
ljwei@jlu.edu.cnLijuan Wei
JLJun-An Li
Jun-An Li
DBDong-Mei Bai
Dong-Mei Bai
YSYing Song
Ying Song

2 June 2025 in Biomaterials
Verified
Journal Article
Closed access
WSWei Sun
Wei Sun
ZLZhibo Li
Zhibo Li
XZXiaohao Zhang
Xiaohao Zhang
QLQiang Luo
Qiang Luo
ljwei@jlu.edu.cnLijuan Weiljwei@jlu.edu.cnLijuan Wei
ljwei@jlu.edu.cnLijuan Wei
CXChunsheng Xiao
Chunsheng Xiao

13 October 2023 in Frontiers in Immunology
Verified
Journal Article
Open access
相仪 宋相仪 宋
相仪 宋
Ruifeng DuanRuifeng Duan
Ruifeng Duan
LDLiwei Duan
Liwei Duan
ljwei@jlu.edu.cnLijuan Weiljwei@jlu.edu.cnLijuan Wei
ljwei@jlu.edu.cnLijuan Wei
Immune reconstitution inflammatory syndrome (IRIS) is characterized by exaggerated and dysregulated inflammatory responses that occur as a result of reconstitution of adaptive or innate immunity. A wide range of microorganisms have been found to be associated with IRIS, such as human immunodeficiency virus (HIV), Mycobacterium and actinobacteria. Whipple disease (WD) is an infectious disorder caused by the Gram-positive bacterium Tropheryma whipplei (T. whipplei) and IRIS also serves as a complication during its treament. Although many of these pathological mechanisms are shared with related inflammatory disorders, IRIS in WD exhibits distinct features and is poorly described in the medical literature. Novel investigations of the intestinal mucosal immune system have provided new insights into the pathogenesis of IRIS, elucidating the interplay between systemic and local immune responses. These insights may be used to identify monitoring tools for disease prevention and to develop treatment strategies. Therefore, this review synthesizes these new concepts in WD IRIS to approach the feasibility of manipulating host immunity and immune reconstitution of inflammatory syndromes from a newer, more comprehensive perspective and study hypothetical options for the management of WD IRIS.

9 April 2025 in BMC Gastroenterology
Verified
Journal Article
Open access
PDF file
RDRuifeng Duan
Ruifeng Duan
LDLiwei Duan
Liwei Duan
XCXin Chen
Xin Chen
MLMin Liu
Min Liu
XSXiangyi Song
Xiangyi Song
ljwei@jlu.edu.cnLijuan Weiljwei@jlu.edu.cnLijuan Wei
ljwei@jlu.edu.cnLijuan Wei
Gastric stromal tumors (GSTs) and gastric leiomyomas (GLs) represent the primary subtypes of gastric submucosal tumors (SMTs) characterized by distinct biological characteristics and treatment modalities. The accurate differentiation between GSTs and GLs poses a significant clinical challenge. Recent advancements in artificial intelligence (AI) leveraging endoscopic ultrasonography (EUS) have demonstrated promising results in the categorization of larger-diameter SMTs (> 2.0 cm). However, the diagnostic capacity of AI models for micro-diameter SMTs (< 1.0 cm) remains uncertain due to limited imaging features. This study seeks to develop a specialized diagnostic model utilizing EUS images to differentiate small and micro GSTs from GLs effectively. In this study, a dataset comprising 358 EUS images of GSTs or GLs was utilized for training the EUS-AI model. Subsequently, 216 EUS images were allocated for validation purposes, with 159 images in validation set 1 (micro SMTs: tumor diameter < 1.0 cm) and 216 images in validation set 2 (small SMTs: tumor diameter < 2.0 cm). The diagnostic performance of the EUS-AI model for individual tumors was assessed by consolidating the diagnostic outcomes of the corresponding images. Comparative analyses were conducted between the diagnostic outcomes of endoscopists, clinical signatures, and those of the EUS-AI models. The EUS-AI models were developed using DenseNet201, ResNet50, and VGG19 architectures. Among the three models, the ResNet50 model demonstrated superior performance on EUS images, achieving area under the curve (AUC) values of 0.938, 0.832, and 0.841 in the training set, validation set 1, and validation set 2, respectively. By combining predictions from multiple images for each tumor, the diagnostic efficacy of ResNet50 was further enhanced, resulting in AUCs of 0.994, 0.911, and 0.915 in the aforementioned sets. In comparison, both clinical signatures and endoscopists exhibited notably lower AUC values than those obtained with the EUS-AI model. The EUS-AI model utilizing ResNet50 architecture effectively discriminates between micro GSTs and GLs from both image-centric and tumor-centric perspectives. Demonstrating superior diagnostic efficiency compared to clinical models and assessments by endoscopists, the EUS-AI model serves as a valuable tool for clinicians in precisely distinguishing small and micro GSTs from GLs before surgery.

1 January 2020
Verified
Journal Article
Closed access
ljwei@jlu.edu.cnLijuan Weiljwei@jlu.edu.cnLijuan Wei
ljwei@jlu.edu.cnLijuan Wei
DBD-M Bai
D-M Bai
ZWZ-Y Wang
Z-Y Wang
BLB-C Liu
B-C Liu

11 July 2022 in European Journal of Pharmacology
Verified
Journal Article
Closed access
ljwei@jlu.edu.cnLijuan Weiljwei@jlu.edu.cnLijuan Wei
ljwei@jlu.edu.cnLijuan Wei
LDLiwei Duan
Liwei Duan
HZHongyu Zhao
Hongyu Zhao
JTJinghua Tai
Jinghua Tai